BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16260484)

  • 1. Incarcerated clients' perceptions of therapeutic change in substance abuse treatment: a 4-year case study.
    Smiley-McDonald HM; Leukefeld CG
    Int J Offender Ther Comp Criminol; 2005 Oct; 49(5):574-89. PubMed ID: 16260484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of therapeutic engagement in prison-based drug treatment.
    Welsh WN; McGrain PN
    Drug Alcohol Depend; 2008 Aug; 96(3):271-80. PubMed ID: 18486361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance abuse treatment for mothers: treatment outcomes and the impact of length of stay.
    Conners NA; Grant A; Crone CC; Whiteside-Mansell L
    J Subst Abuse Treat; 2006 Dec; 31(4):447-56. PubMed ID: 17084800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use and treatment seeking in young offenders on community orders.
    Lennings CJ; Kenny DT; Nelson P
    J Subst Abuse Treat; 2006 Dec; 31(4):425-32. PubMed ID: 17084797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are prisoner characteristics associated with therapeutic community treatment process?
    Chan KS; Wenzel S; Mandell W; Orlando M; Ebener P
    Am J Drug Alcohol Abuse; 2007; 33(2):267-79. PubMed ID: 17497550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and benefits of combining probation and substance abuse treatment.
    Alemi F; Taxman F; Baghi H; Vang J; Thanner M; Doyon V
    J Ment Health Policy Econ; 2006 Jun; 9(2):57-70. PubMed ID: 17007484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment process in the therapeutic community: associations with retention and outcomes among adolescent residential clients.
    Edelen MO; Tucker JS; Wenzel SL; Paddock SM; Ebener P; Dahl J; Mandell W
    J Subst Abuse Treat; 2007 Jun; 32(4):415-21. PubMed ID: 17481465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problem severity and motivation for treatment in incarcerated substance abusers.
    Hiller ML; Narevic E; Webster JM; Rosen P; Staton M; Leukefeld C; Garrity TF; Kayo R
    Subst Use Misuse; 2009; 44(1):28-41. PubMed ID: 19137481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizational context, systems change, and adopting treatment delivery systems in the criminal justice system.
    Taxman FS; Henderson CE; Belenko S
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1():S1-6. PubMed ID: 19423241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI).
    Paddock SM; Edelen MO; Wenzel SL; Ebener P; Mandell W; Dahl J
    Am J Drug Alcohol Abuse; 2007; 33(4):537-46. PubMed ID: 17668339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug offenders' perceptions of motivation: the role of motivation in rehabilitation and reintegration.
    Gideon L
    Int J Offender Ther Comp Criminol; 2010 Aug; 54(4):597-610. PubMed ID: 19299528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intellectual abilities and motivation toward substance abuse treatment in drug-involved offenders: a pilot study in the Belgian criminal justice system.
    Vandevelde S; Broekaert E; Schuyten G; Van Hove G
    Int J Offender Ther Comp Criminol; 2005 Jun; 49(3):277-97. PubMed ID: 15851508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The success of therapeutic communities for substance abusers in American prisons.
    Wexler HK
    J Psychoactive Drugs; 1995; 27(1):57-66. PubMed ID: 7602441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and recovery as perceived by patients with substance addiction.
    Nordfjaern T; Rundmo T; Hole R
    J Psychiatr Ment Health Nurs; 2010 Feb; 17(1):46-64. PubMed ID: 20100306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
    Gossop M; Stewart D; Marsden J
    Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further validity evidence for the dimensions of change in therapeutic community treatment instrument.
    Edelen MO; Miles JN; Osilla KC; Wenzel SL
    Am J Drug Alcohol Abuse; 2008; 34(3):285-92. PubMed ID: 18428071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis of three treatment modalities in a residential substance abuse program for women and children.
    McComish JF; Greenberg R; Ager J; Chruscial H; Laken MA
    Outcomes Manag Nurs Pract; 2000; 4(2):71-7. PubMed ID: 11111587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified therapeutic community treatment for offenders with MICA disorders: substance use outcomes.
    Sullivan CJ; McKendrick K; Sacks S; Banks S
    Am J Drug Alcohol Abuse; 2007; 33(6):823-32. PubMed ID: 17994478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.